Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/11/2003US20030228307 Binding to platelet derived growth factor
12/11/2003US20030228301 Genetic engineering; polypeptide binding to antibody
12/11/2003US20030228298 Antiproliferative agents
12/11/2003US20030228297 Lactobacilli expressing biologically active polypeptides and uses thereof
12/11/2003US20030228292 Methods of inducing or enhancing connective tissue repair
12/11/2003US20030228291 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003US20030228259 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
12/11/2003US20030228258 Suicide tetramers and uses thereof
12/11/2003DE3943825C2 Incorporation of DNA into higher plant genome
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2736921A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2494451A1 Treatment of cell proliferative disorders with chlorotoxin
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2490051A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003CA2488539A1 Novel proteins and nucleic acids encoding same
12/11/2003CA2488234A1 Immunomodulatory constructs and their uses
12/11/2003CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2488006A1 A human cell assay to determine effect of sample compounds on col2 enhancer expression
12/11/2003CA2487939A1 Semaphorin-like proteins and methods of using same
12/11/2003CA2487926A1 Suicide tetramers comprising mhc class i and uses thereof
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487901A1 Variants of antithrombin iii
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487815A1 Targeted therapeutic proteins
12/11/2003CA2487724A1 Immunogenic sequences
12/11/2003CA2487513A1 Improved receptor detection
12/11/2003CA2487425A1 Combination chemotherapy with chlorotoxin
12/11/2003CA2487410A1 Intramyocardial injection of autologous bone marrow
12/11/2003CA2487291A1 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
12/11/2003CA2487137A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2486980A1 Attenuated listeria spp. and methods for using the same
12/11/2003CA2485653A1 Human 5-ht7 receptor promoter sequence
12/11/2003CA2480326A1 Knockout mice and their use
12/10/2003EP1369695A1 Method for identifying type-I interferon responsive MS patients by determining TRAIL expression
12/10/2003EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369482A1 Target genes for the diagnosis and treatment of cancer
12/10/2003EP1369481A1 Novel translational activity-promoting higher-order structure
12/10/2003EP1369479A1 Novel cell adhesion molecule specific to activated leukocyte
12/10/2003EP1369478A1 Novel scavenger receptor class a protein
12/10/2003EP1369476A1 A novel protein, a gene encoding therefor and a method of using the same
12/10/2003EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR
12/10/2003EP1369429A1 GCSF conjugates
12/10/2003EP1369428A1 Muc-1 derivatives and their use in treating cancer-associated MUC-1 Mucin-induced immunosuppression
12/10/2003EP1369427A2 HIV-3 retrovirus strains and their use
12/10/2003EP1369426A1 Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1369126A1 Use of coding microsatellite region frameshift mutation-derived peptides for treating cancer
12/10/2003EP1369125A1 Treatment of partial growth hormone insensitivity syndrome
12/10/2003EP1368660A2 Assay
12/10/2003EP1368656A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
12/10/2003EP1368647A2 Proteins, genes and their use for diagnosis and treatment of vascular response
12/10/2003EP1368579A2 Synthetic molecular spring device
12/10/2003EP1368499A2 Rat toxicologically relevant genes and uses thereof
12/10/2003EP1368484A2 Plant genes, the expression of which are altered by pathogen infection
12/10/2003EP1368483A2 Process for production of polypeptides
12/10/2003EP1368478A2 Polypeptide inducing hiv-neutralising antibodies
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii
12/10/2003EP1368475A1 Novel nucleic acids and polypeptides
12/10/2003EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368472A2 Molecules for disease detection and treatment
12/10/2003EP1368471A2 Compositions and methods relating to prostate specific genes and proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368468A1 83 human secreted proteins
12/10/2003EP1368467A2 Putrescine-n-methyltransferase promoter
12/10/2003EP1368466A2 Transgenic cell and animal modeling ige-mediated human allergic responses and use thereof
12/10/2003EP1368464A2 Screening assays for agonists or antagonists of receptor activator of nf-kb
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368454A1 Method for detecting a risk of hypertension and uses thereof
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368376A2 Pro-apoptotic proteins and dna molecules encoding them
12/10/2003EP1368375A2 Secretory molecules
12/10/2003EP1368374A2 Cctra gene as a tool for the generation of a male progeny in the mediterranean fruitfly ceratitis capitata
12/10/2003EP1368373A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368064A2 Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
12/10/2003EP1368058A2 Viral reporter particles
12/10/2003EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368050A2 Virus derived antimicrobial peptides
12/10/2003EP1368049A2 Inhibition of atf2 activity to treat cancer
12/10/2003EP1367908A2 Expression of human milk proteins in transgenic plants
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1148897B1 Methods and compositions for healing and repair of articular cartilage
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
1 ... 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 ... 2916